Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119969) titled 'Exploratory Study of Preoperative Transarterial Chemoembolization (TACE) in Treatment-Naive, Resectable Hepatocellular Carcinoma' on March 6.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Lishui Central Hospital

Condition: Hepatocellular Carcinoma (HCC)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-15

Target Sample Size: Experimental group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=309689

Published by HT Digital Content Services with permission from Health Daily Digest....